Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$306.88 - $380.0 $385,134 - $476,900
1,255 Added 25.95%
6,092 $2.31 Million
Q3 2023

Nov 13, 2023

SELL
$315.92 - $397.36 $64,447 - $81,061
-204 Reduced 4.05%
4,837 $1.54 Million
Q2 2023

Aug 11, 2023

BUY
$346.15 - $392.09 $143,306 - $162,325
414 Added 8.95%
5,041 $1.93 Million
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $147,543 - $170,252
456 Added 10.93%
4,627 $1.73 Million
Q4 2022

Feb 14, 2023

BUY
$248.67 - $334.17 $132,541 - $178,112
533 Added 14.65%
4,171 $1.38 Million
Q3 2022

Nov 10, 2022

BUY
$263.81 - $337.27 $959,740 - $1.23 Million
3,638 New
3,638 $960,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.